Pricing

Log inSign up

Cyanvac

7 people · 0 jobs
‌

Cyanvac develops vaccines using a proprietary transformational parainfluenza virus 5 (PIV5)-based vector.

Industries

Biotechnology, Health Care

Headquarters

Athens, United States

Links

Org chart

Fred C. Davison
Chief Executive Officer
Collapse
Gary Titus
Chief Financial Officer
Hong Jin
Chief Scientific Officer
Marinka Tellier
Chief Regulatory Officer
Samuel Wu
Chief Business Officer

Teams

This company has no teams yet

Offices

Similar companies

AtriCure

4 followers

Merck

283 followers

AbbVie

276 followers

Abbott

383 followers

Amgen

280 followers

Agiliti

7 followers

Elanco

28 followers

Taiho Oncology, Inc.

2 followers

Revvity

9 followers

Truepill

6 followers

DM Clinical Research

15 followers

Explore companies